These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23016949)

  • 21. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
    Bender SW
    Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
    Schaiquevich P; Niselman A; Rubio M
    Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
    Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
    Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative bioavailability of two oral formulations of ranitidine.
    Flores-Murrieta FJ; Toledo A; del Carmen Carrasco-Portugal M; Reyes-García G; Rodríguez-Silverio J; Medina-Santillán R; Herrera JE
    Biopharm Drug Dispos; 2006 Jan; 27(1):23-7. PubMed ID: 16278926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation.
    Wells TG; Heulitt MJ; Taylor BJ; Fasules JW; Kearns GL
    J Clin Pharmacol; 1998 May; 38(5):402-7. PubMed ID: 9602950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
    Richards DA
    J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers.
    Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A
    Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
    Yin OQ; Tomlinson B; Chow AH; Chow MS
    Clin Pharmacokinet; 2003; 42(2):179-92. PubMed ID: 12537516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK; DiCicco RA; Freed MI
    Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
    Blouin RA; Kneer J; Ambros RJ; Stoeckel K
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketoconazole and rifampicin on the pharmacokinetics of ranitidine in healthy human volunteers: a possible role of P-glycoprotein.
    Machavaram KK; Gundu J; Yamsani MR
    Drug Metabol Drug Interact; 2006; 22(1):47-65. PubMed ID: 17152347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.